Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Update
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 3,970,000 shares, an inc
Cytek Biosciences, Inc. (NASDAQ:CTKB) Holdings Raised by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC grew its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) by 54.4% in the 3rd quarter, according to the company in its most recent Form
Cytek Biosciences, Inc. (NASDAQ:CTKB) CFO Patrik Jeanmonod Sells 3,500 Shares
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CFO Patrik Jeanmonod sold 3,500 shares of the company's stock in a transaction on Tuesday, January 24th. The stock was sold at an average price of $
Ming Yan Sells 20,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CTO Ming Yan sold 20,000 shares of the firm's stock in a transaction on Thursday, January 19th. The shares were sold at an average price of $11.03,
Cytek Biosciences (NASDAQ:CTKB) Shares Down 7.5%
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) shares dropped 7.5% during mid-day trading on Thursday . The company traded as low as $10.91 and last traded at $10.92. Approximately 9,581 shares w
Cytek Biosciences (NASDAQ:CTKB) Shares Down 3% Following Insider Selling
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating)'s stock price was down 3% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $10.32 and last trad
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today's pre-market trading session.Sotera Health Company (NASDAQ:SHC) shares climbed 42.7% to $12.33 in pre-m
Global Flow Cytometry Market Report to 2027 - Players Include Bio-Techne, Cell Signaling Technology, Coherent and Cytek Biosciences - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Flow Cytometry: Products, Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide a comprehensive study o
Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Significant Growth in Short Interest
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 3,470,
Cytek Biosciences (NASDAQ:CTKB) Shareholders Have Endured a 37% Loss From Investing in the Stock a Year Ago
Loading...
No Stock Yet